Insider Trading Alert - METR, CMN And SWK Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 15, 2014, 114 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $538.00 to $2,081,081.25.

Highlighted Stocks Traded by Insiders:

Metro Bancorp (METR) - FREE Research Report

Gelder Douglas S, who is Director at Metro Bancorp, sold 1,000 shares at $25.51 on Dec. 15, 2014. Following this transaction, the Director owned 119,451 shares meaning that the stake was reduced by 0.83% with the 1,000-share transaction.

The shares most recently traded at $24.37, down $1.14, or 4.68% since the insider transaction. Historical insider transactions for Metro Bancorp go as follows:

  • 4-Week # shares bought: 100
  • 4-Week # shares sold: 5,260
  • 12-Week # shares bought: 1,100
  • 12-Week # shares sold: 5,260
  • 24-Week # shares bought: 1,100
  • 24-Week # shares sold: 5,260

The average volume for Metro Bancorp has been 30,000 shares per day over the past 30 days. Metro Bancorp has a market cap of $357.2 million and is part of the financial sector and banking industry. Shares are up 14.16% year-to-date as of the close of trading on Friday.

Metro Bancorp, Inc. operates as the bank holding company for Metro Bank, which provides retail and commercial banking services for consumers, and small and mid-sized companies in Pennsylvania. The company has a P/E ratio of 17.8. Currently, there are no analysts who rate Metro Bancorp a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on METR - FREE

TheStreet Quant Ratings rates Metro Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, solid stock price performance, expanding profit margins and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Metro Bancorp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cantel Medical (CMN) - FREE Research Report

Nodiff Eric W, who is EVP and General Counsel at Cantel Medical, sold 5,000 shares at $44.21 on Dec. 15, 2014. Following this transaction, the EVP and General Counsel owned 72,374 shares meaning that the stake was reduced by 6.46% with the 5,000-share transaction.

The shares most recently traded at $42.45, down $1.76, or 4.15% since the insider transaction. Historical insider transactions for Cantel Medical go as follows:

  • 4-Week # shares sold: 14,000
  • 12-Week # shares sold: 119,750
  • 24-Week # shares sold: 131,312

The average volume for Cantel Medical has been 121,100 shares per day over the past 30 days. Cantel Medical has a market cap of $1.8 billion and is part of the health care sector and health services industry. Shares are up 27.69% year-to-date as of the close of trading on Friday.

Cantel Medical Corp. provides infection prevention and control products and services in the healthcare market. The stock currently has a dividend yield of 0.23%. The company has a P/E ratio of 42.6. Currently, there is 1 analyst who rates Cantel Medical a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMN - FREE

TheStreet Quant Ratings rates Cantel Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Cantel Medical Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Stanley Black & Decker (SWK) - FREE Research Report

Sohovich JoAnna, who is President, IAR at Stanley Black & Decker, sold 801 shares at $94.10 on Dec. 15, 2014. Following this transaction, the President, IAR owned 26,823 shares meaning that the stake was reduced by 2.9% with the 801-share transaction.

The shares most recently traded at $92.91, down $1.19, or 1.28% since the insider transaction. Historical insider transactions for Stanley Black & Decker go as follows:

  • 4-Week # shares sold: 8,084
  • 12-Week # shares sold: 10,764
  • 24-Week # shares sold: 50,548

The average volume for Stanley Black & Decker has been 1.2 million shares per day over the past 30 days. Stanley Black & Decker has a market cap of $14.9 billion and is part of the industrial goods sector and industrial industry. Shares are up 16.12% year-to-date as of the close of trading on Friday.

Stanley Black & Decker, Inc. provides power and hand tools, mechanical access solutions, and electronic security and monitoring systems for various industrial applications. The stock currently has a dividend yield of 2.19%. The company has a P/E ratio of 21.9. Currently, there are 6 analysts who rate Stanley Black & Decker a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SWK - FREE

TheStreet Quant Ratings rates Stanley Black & Decker as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, increase in net income, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Stanley Black & Decker Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%